4Hata S, Emi Y, Iyanagi T,et al. cDNA cloning of a putative G protein-coupled receptor from brain[J]. Biochim Biophys Acta,1995,1261(1):121-125.
5Tsou MF, Hayashi A, Rose LS. LET-99 opposes Galpha/GPR signaling to generate asymmetry for spindle positioning in response to PAR and MES-1/SRC-1 signaling[J]. Development,2003,130(23):5717-5730.
6Zhang Q, Thomas SM, Xi S, et al. SRC family kinases mediated epidermal growth factor receptor ligand cleavage proliferation, and invasion of head and neck cancer cues[J]. Cancer Res, 2004,64(17):6166-6173.
7Crespo P, Xu N, Simonds WF, et al. Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits[J]. Nature, 1994,369(6479):418-420.
8Kawanabe Y, Masaki T, Hashimoto N. Involvement of epidermal growth factor receptor-protein tyrosine kinase transactivation in endothlin-1-induced vascular contraction[J]. J Neurosurg,2004,100(6):1066-1071.
10Uckun FM, Mao C. Tyrosine kinases as new molecular targets in treatment of inflammatory disorders and leukemia[J]. Curr Pharm Des,2004,10(10):1083-1091.
6[1]Kerr J,Leary JA,Hurst T,et al.Allelic loss on chromosome 7q in ovarian adenocareinomas:two critical regions and rearrangement of the PLANHl locus[J].Oncogene,1996,13:1815-1818.
7[2]Stumpf E,Aalto Y,Hoog A,et al.Chromosomal alterations in human pancreatic endocrine tumors [ J ].Genes Chromosomes Cancer,2000,29(1):83-87.
8[3]Lakka SS,Konduri SD,Mohanam S,et al.In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2 [ J ].Clin Exp Metastasis,2000,18:239-244.
9[4]Miyagi Y,Yasumitsu H,Miyata S,et al.Assignment of the human PPS/TFPI-2 gene to 7Q by FISH and PCR-based human mapping panel analysis [ J ].Genomics,1996,35:267-268.
4Alevizos I, Mahadevappa M, Zhang X, et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis [J]. Oncogene, 2001, 20(43): 6196-6204.
5Ha PK, Califano JA 3rd.The molecular biology of laryngeal cancer [J]. Otolaryngol Clin North Am, 2002, 35(5): 993-1012.
6Han J, Kioi M, Chu WS, et al. Identification of potential therapeutic targets in human head & neck squamous cellcarcinoma[J]. Head Neck Oncol, 2009, 1:27.
7Elahi A, Bendaly J, Zheng Z, et al. Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk[J]. Cancer, 2003, 98(4): 872-880.
8Kim M J, Lee JC, Lee J J, et al. Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines [J]. Tumour Biol, 2008, 29 (1):28-34.
9Belbin TJ, Singh B, Barber I, et al. Molecular classifica- tion of head and neck squarnous cell carcinoma using cDNA microarrays [J]. Cancer Res, 2002, 62 (4):1184- 1190.
10Wang H, Owens JD, Shih JH, et al. Histological staining methods preparatory to laser capture microdissection significantly affect the integrity of the cellular RNA [J]. BMC Genomics, 2006, 7:97.
